The paradox of clozapine in Black people with treatment-resistant schizophrenia

被引：0
作者：
Whiskey, Eromona [1 ,2 ]
Bachmann, Christian [3 ]
Dzahini, Olubanke [1 ,2 ]
Taylor, David [1 ,2 ]
Oloyede, Ebenezer [1 ,4 ]
机构：
[1] Maudsley Hosp & Inst Psychiat, Pharm Dept, London, England
[2] Kings Coll London, Inst Pharmaceut Sci, London, England
[3] Univ Hosp Ulm, Dept Child & Adolescent Psychiat, Ulm, Germany
[4] Univ Oxford, Dept Psychiat, Oxford, England
来源：
NATURE MENTAL HEALTH | 2025年 / 3卷 / 04期
关键词：
BENIGN ETHNIC NEUTROPENIA; UNTREATED PSYCHOSIS; MENTAL-HEALTH; RACIAL DISPARITIES; PRESCRIPTION PATTERNS; DURATION; PATHWAYS; DISCONTINUATION; CARE; SERVICES;
D O I：
10.1038/s44220-025-00411-9
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
Clozapine is currently the only licensed medication for treatment-resistant schizophrenia (TRS). Ethnic inequalities in treatment with clozapine have been described extensively, particularly regarding the effect on Black ethnic groups. Here we explore the reasons for clozapine underuse in this population, identifying potential misconceptions and providing suggestions to address these barriers.
引用
收藏
页码：402 / 407
页数：6
相关论文
共 85 条
[51]  
Moeller F G, 1995, Ann Clin Psychiatry, V7, P167, DOI 10.3109/10401239509149622
[52]   Duration of untreated psychosis and ethnicity in the ÆSOP first-onset psychosis study [J].
Morgan, C ;
Fearon, P ;
Hutchinson, G ;
McKenzie, K ;
Lappin, JM ;
Abdul-Al, R ;
Morgan, K ;
Dazzan, P ;
Boydell, J ;
Harrison, G ;
Craig, T ;
Leff, J ;
Jone, P ;
Murray, R .
PSYCHOLOGICAL MEDICINE, 2006, 36 (02) :239-247
[53]   Pathways to care and ethnicity. 2: Source of referral and help-seeking - Report from the AESOP study [J].
Morgan, C ;
Mallett, R ;
Hutchinson, G ;
Bagalkote, H ;
Morgan, K ;
Fearon, P ;
Dazzan, P ;
Boydell, J ;
McKenzie, K ;
Harrison, G ;
Murray, R ;
Jones, P ;
Craig, T ;
Leff, J .
BRITISH JOURNAL OF PSYCHIATRY, 2005, 186 :290-296
[54]   Active monitoring of 12760 clozapine recipients in the UK and Ireland - Beyond pharmacovigilance [J].
Munro, J ;
O'Sullivan, D ;
Andrews, C ;
Arana, A ;
Mortimer, A ;
Kerwin, R .
BRITISH JOURNAL OF PSYCHIATRY, 1999, 175 :576-580
[55]   Worldwide Differences in Regulations of Clozapine Use [J].
Nielsen, Jimmi ;
Young, Corina ;
Ifteni, Petru ;
Kishimoto, Taishiro ;
Xiang, Yu-Tao ;
Schulte, Peter F. J. ;
Correll, Christoph U. ;
Taylor, David .
CNS DRUGS, 2016, 30 (02) :149-161
[56]   Predictors of Clozapine Response in Patients With Treatment-Refractory Schizophrenia Results From a Danish Register Study [J].
Nielsen, Jimmi ;
Nielsen, Rene Ernst ;
Correll, Christoph U. .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (05) :678-683
[57]   Ethnic variations in duration of untreated psychosis: report from the CRIS-FEP study [J].
Oduola, Sherifat ;
Craig, Tom K. J. ;
Morgan, Craig .
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2021, 56 (06) :931-941
[58]   Identifying clinically relevant agranulocytosis in people registered on the UK clozapine Central Non-Rechallenge Database: retrospective cohort study [J].
Oloyede, Ebenezer ;
Bachmann, Christian J. ;
Dzahini, Olubanke ;
Alcaraz, Juan Miguel Lopez ;
Singh, Shaurya Dev ;
Vallianatu, Kalliopi ;
Funk, Burkhardt ;
Whiskey, Eromona ;
Taylor, David .
BRITISH JOURNAL OF PSYCHIATRY, 2024, 225 (05) :484-491
[59]   The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia [J].
Oloyede, Ebenezer ;
Dunnett, Danielle ;
Taylor, David ;
Clark, Ivana ;
MacCabe, James H. ;
Whiskey, Eromona ;
Onwumere, Juliana .
BMC PSYCHIATRY, 2023, 23 (01)
[60]   What are the barriers and facilitators of clozapine use in early psychosis? A survey of UK early intervention clinicians [J].
Oloyede, Ebenezer ;
Blackman, Graham ;
Mantell, Bethany ;
Harris, Eleanor ;
Williams, Julie ;
Taylor, David ;
MacCabe, James ;
McGuire, Philip .
SCHIZOPHRENIA, 2023, 9 (01)
123456789